EUVIMEDEUVIMED entdecken
Crossref

Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer

Shinsuke Hara, Daisuke Sakai, Kenji Ikemura, Takuya Shintani, Tomoya Yamamoto, Taroh Satoh, Masahiro Okuda

Anticancer Research · 2024

DOI: 10.21873/anticanres.16917 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Shinsuke Hara und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Osaka University Hospital, Suita, Japan. Hauptthemen laut MEDLINE: Frontotemporal Dementia, Colorectal Neoplasms, Colonic Neoplasms, Rectal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Frontotemporal DementiaColorectal NeoplasmsColonic NeoplasmsRectal NeoplasmsPyrrolidinesThymineHumansUracilRetrospective StudiesTrifluridineDrug CombinationsAntineoplastic Combined Chemotherapy Protocols

Stichwörter der Autor:innen

Biweekly regimencolorectal cancerstandard regimentrifluridine/tipiracil

Substanzen

tipiracilUracilTrifluridineDrug CombinationsPyrrolidinesThymine

Autor:innen und Institutionen

  • Department of Pharmacy, Osaka University Hospital, Suita, Japan.
  • Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Suita, Japan.
  • Department of Pharmacy, Osaka University Hospital, Suita, Japan; ikemurak@hp-drug.med.osaka-u.ac.jp.

Zitieren

APA

Hara, S., Sakai, D., Ikemura, K., Shintani, T., Yamamoto, T., Satoh, T., & Okuda, M. (2024). Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.16917

Vancouver

Hara S, Sakai D, Ikemura K, Shintani T, Yamamoto T, Satoh T, et al. Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer. Anticancer Research. 2024. doi:10.21873/anticanres.16917

BibTeX
@article{Hara2024,
  author = {Hara, Shinsuke and Sakai, Daisuke and Ikemura, Kenji and Shintani, Takuya and Yamamoto, Tomoya and Satoh, Taroh and Okuda, Masahiro},
  title = {Comparative Efficacy and Safety of Standard and Biweekly Trifluridine/Tipiracil Regimen in Patients With Colorectal Cancer},
  journal = {Anticancer Research},
  year = {2024},
  doi = {10.21873/anticanres.16917}
}
Kostenlos starten →